1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience.
Saved in:
| Title: | 1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience. |
|---|---|
| Authors: | Bas, O.1 (AUTHOR), Sert, L.2 (AUTHOR), Balcik, O.Y.3 (AUTHOR), Tokatli, M.4 (AUTHOR), Boyraz, N.E.4 (AUTHOR), Kavgaci, G.5 (AUTHOR), Sahin, T.K.6 (AUTHOR), Guven, D.C.7 (AUTHOR), Arik, Z.8 (AUTHOR), Isikdogan, A.2 (AUTHOR), Erman, M.9 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1090-S1090. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
